Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Heron Therapeutics (HRTX) Return on Assets: 2011-2025

Historic Return on Assets for Heron Therapeutics (HRTX) over the last 11 years, with Sep 2025 value amounting to 0.01%.

  • Heron Therapeutics' Return on Assets rose 12.00% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 12.00%. This contributed to the annual value of -0.06% for FY2024, which is 41.00% up from last year.
  • According to the latest figures from Q3 2025, Heron Therapeutics' Return on Assets is 0.01%, which was up 26.07% from 0.01% recorded in Q2 2025.
  • Over the past 5 years, Heron Therapeutics' Return on Assets peaked at 0.01% during Q3 2025, and registered a low of -0.84% during Q2 2022.
  • Its 3-year average for Return on Assets is -0.28%, with a median of -0.21% in 2024.
  • As far as peak fluctuations go, Heron Therapeutics' Return on Assets dropped by 28bps in 2021, and later skyrocketed by 44bps in 2024.
  • Over the past 5 years, Heron Therapeutics' Return on Assets (Quarterly) stood at -0.66% in 2021, then fell by 1bps to -0.67% in 2022, then climbed by 18bps to -0.49% in 2023, then spiked by 44bps to -0.05% in 2024, then climbed by 12bps to 0.01% in 2025.
  • Its Return on Assets stands at 0.01% for Q3 2025, versus 0.01% for Q2 2025 and -0.02% for Q1 2025.